Cue Biopharma Market Sentiment

Cue Biopharma Inc

CUENASDAQ

$17.04

0.965.97%

Dern. MÀJ: Oct 20, 8:48 AM

$16.15

0.070.44%

Cue Biopharma Market Sentiment - Benzinga

Market sentiment signals for Cue Biopharma (CUE): analyst consensus, short interest, options flow and insider activity.

Analyst Consensus▲ Buy

Short Interest▼ 10.2% short float

Options Flow— N/A

Insider Activity▼ Net Seller (30d)

Analyst Consensus

Buy

8 analysts

Options Flow (P/C)

—

Avg Consensus PT

$127

+684.1%

Highest Price Target

$300

+1757.6%

Oppenheimer

Lowest Price Target

$60

+271.5%

Citizens Capital Markets

Short Interest

10.2%

Rising — Bearish

Insider Activity (30d)

Net Seller

Short Interest — % of Float

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Sep 18, 2026	B. Riley Securities	Mayank Mamtani—	+413.9%	$83	Initiate	Buy
Aug 25, 2025	LUCID CAPITAL MARKETS	Dev Prasad —	-75.2%	$4	Initiate	Buy
Apr 2, 2025	Citizens Capital Markets	Reni Benjamin—	-87.6%	$2 → $2	Maintained	Market Outperform
Aug 20, 2024	Stifel	Stephen Willey—	-75.2%	$8 → $4	Maintained	Buy
Jul 26, 2024	JMP Securities	Reni Benjamin—	-87.6%	$15 → $2	Maintained	Market Outperform
Jul 26, 2024	Piper Sandler	Edward Tenthoff—	-81.4%	$8 → $3	Maintained	Overweight
Apr 9, 2024	Stifel	Stephen Willey—	-50.5%	$8 → $8	Maintained	Buy
Apr 9, 2024	Oppenheimer	Leland Gershell—	-38.1%	$10 → $10	Maintained	Outperform
Apr 3, 2024	Piper Sandler	Edward Tenthoff—	-50.5%	$8 → $8	Maintained	Overweight
Mar 13, 2024	Jefferies	Maury Raycroft—	-62.8%	$6	Initiate	Buy
Nov 6, 2023	Piper Sandler	Edward Tenthoff—	-50.5%	$7 → $8	Maintained	Overweight